U.S. tariffs trigger refund uncertainty

Tariffs are supposed to be simple. The government adds a tax at the border, importers pay it, and everyone adjusts. But the U.S. tariff picture right now is the opposite of simple — one big set of Trump tariffs got knocked out by the Supreme Court, while newer tariffs on semiconductors and pharmaceuticals are still moving ahead. That creates a weird in-between moment. Some companies may be owed money back. Others are still staring at fresh bills. ### Which tariffs got struck down? The big legal shock came on February 20, 2026, when the Supreme Court ruled 6-3 that Trump’s administration had gone too far using the International Emergency Economic Powers Act, or IEEPA, to impose broad tariffs. That matters because IEEPA was the legal engine for some of the administration’s sweeping tariff actions. The ruling did not erase every Trump tariff. It knocked out the ones built on that specific statute. (gtlaw.com) ### Why do refunds suddenly look possible? Because importers, not foreign exporters, are the ones that actually pay tariffs at the border. If those duties were collected under an unlawful legal theory, companies that paid them can try to recover the money. That is why businesses are filing protests and protective claims now. The catch is timing — refund r(gtlaw.com)fund likely” does not mean “check arrives automatically.” (gtlaw.com) ### Who is the obvious example? Basic Fun! — the toy company behind brands like Care Bears and Tonka — has been used as a public example of a business trying to claim tariff refunds. That is useful because it shows where the money lands first. It lands with importers. Consumers who paid higher prices because tariffs got baked into retail prices are much l(gtlaw.com)tags. (pbs.org) ### So what stayed in force? Section 232 tariffs. That is a different law — the national-security trade statute the White House has been leaning on for newer actions. On January 14, 2026, Trump issued a proclamation imposing a 25% tariff on certain semiconductors, semiconductor-manufacturing equipment, and derivative products, effective just after midnight on January 15. The administration framed that as a supply-chain and defense issue, not an emergency-powers move. (whitehouse.gov) ### What about pharmaceuticals? Those moved faster than the prompt suggests. This is not just an investigation anymore. On April 2, 2026, Trump issued a proclamation on pharmaceuticals and pharmaceutical ingredients under Section 232. A White House fact sheet said the ta(whitehouse.gov)ounced tariff regime. (whitehouse.gov) ### Why is this so confusing for businesses? Because companies are dealing with two opposite motions at once. One part of the tariff wall may be coming down through litigation. Another part is still being built under a different statute the Court did not just reject. So a company can be planning refund claims on old imports while repricing future shipments under new duties. That is terrible for budgeting, inventory planning, and investment decisions. (grantthornton.com) ### Does this uncertainty hit only importers? No. It spreads outward. Suppliers renegotiate contracts. Manufacturers rethink sourcing. Drugmakers and chip buyers reassess whether to localize production, absorb costs, or pass them on. Even allies trying to cut side deals with Washington are working around a moving target — the UK briefing makes that plain in sectors like autos, steel, pharmaceuticals, and semiconductors. (commonslibrary.parliament.uk) ### Bottom line? The clean version of the story is wrong. This is not “tariffs are gone,” and it is not “tariffs are fully back.” It is a split screen. Old IEEPA tariffs may generate refunds. New Section 232 tariffs on chips and pharmaceuticals are still alive. For businesses, that means the biggest cost right now may be uncertainty itself.